MIRENA

This brand name is authorized in Austria, Australia, Brazil, Canada, Cyprus, Ecuador, Estonia, Spain, Finland, France, Hong Kong, Croatia, Ireland, Israel, Japan, Lithuania, Malta, Mexico, Netherlands, New Zealand, Poland, Romania, Singapore, Tunisia, Turkey, United Kingdom, United States, South Africa

Active ingredients

The drug MIRENA contains one active pharmaceutical ingredient (API):

1 Levonorgestrel UNII 5W7SIA7YZW - LEVONORGESTREL

The precise mode of action of levonorgestrel as an emergency contraceptive is not known. At the recommended regimen, levonorgestrel is thought to work mainly by preventing ovulation and fertilisation if intercourse has taken place in the preovulatory phase, when the likelihood of fertilisation is the highest. Read about Levonorgestrel

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
G02BA03	Plastic IUD with progestogen	G Genito urinary system and sex hormones → G02 Other gynecologicals → G02B Contraceptives for topical use → G02BA Intrauterine contraceptives
Discover more medicines within G02BA03
G03AC03	Levonorgestrel	G Genito urinary system and sex hormones → G03 Sex hormones and modulators of the genital system → G03A Hormonal contraceptives for systemic use → G03AC Progestogens
Discover more medicines within G03AC03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 8633J
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 538915090024217
Country: CA	Health Products and Food Branch	Identifier(s): 02243005
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): 30020-10-11
Country: EE	Ravimiamet	Identifier(s): 1009493
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 63158
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 014453
Country: FR	Base de données publique des médicaments	Identifier(s): 66349230
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 34933, 374031
Country: HK	Department of Health Drug Office	Identifier(s): 41251
Country: HR	Agencija za lijekove i medicinske proizvode	Identifier(s): HR-H-494254913
Country: IE	Health Products Regulatory Authority	Identifier(s): 33526, 33578
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 3519
Country: JP	医薬品医療機器総合機構	Identifier(s): 2529710X1027
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1012090, 1060572, 1092333, 1092692
Country: MT	Medicines Authority	Identifier(s): MA639/02201, PI908/05602A
Country: MX	Comisión Federal para la Protección contra Riesgos Sanitarios	Identifier(s): 259M99
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 98590
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 7966
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100157135, 100292360, 100292726, 100324254, 100324691, 100324700, 100326224, 100356610, 100357302, 100359301, 100361309, 100361670, 100384718, 100437515, 100443272, 100455110
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W64655001
Country: SG	Health Sciences Authority	Identifier(s): 07915P
Country: TN	Direction de la Pharmacie et du Médicament	Identifier(s): 7243091
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8699546326716
Country: US	FDA, National Drug Code	Identifier(s): 50419-423
Country: ZA	Health Products Regulatory Authority	Identifier(s): 32/34/0332